Temple reaches $375m valuation in secondary sale, launches ESOP liquidity plan
Deepinder Goyal-founded wellness wearable startup Temple has nearly doubled its valuation from about $190 million through a secondary share sale. The company has also launched its first ESOP liquidity programme as it builds product and team capacity ahead of a commercial wearable launch expected within a year.
What happened
Deepinder Goyal-founded wellness wearable startup Temple doubled its valuation to $375 million through a secondary sale and launched its first ESOP liquidity
Key facts
- $375 million valuation
- Nearly 2x prior valuation of about $190 million
- $54 million previously raised
- $500 million investor-interest valuation
- More than $270 million in startup ESOP buybacks in 2026
- Rs 20 crore Scapia ESOP buyback
- $1 = Rs 95.71
Why this matters
Temple’s higher valuation, Deepinder Goyal linkage and talent-retention push make it a more credible wearable-health partnership or acquisition-watch candidate ahead of launch.
What to watch
- Confirmation of launch timing, product category, pricing and target geography.
- Evidence of proprietary sensing capabilities, clinical validation, accuracy benchmarks or regulatory strategy.
- New executive and engineering hires, especially in hardware operations, AI, health science and growth.
- Manufacturing partnerships, certification milestones, supply-chain commitments or reported production volumes.
- Details on monetization, including device margin, subscription attachment and corporate-wellness offerings.
- A primary financing round, strategic investor, retail/distribution partnership or acquisition interest.
- Early signs of employee retention after the ESOP liquidity program.
- Use the ESOP liquidity event to retain key engineering, data-science, industrial-design and product leaders through launch.
- Accelerate hiring and supplier commitments for hardware development, testing, manufacturing readiness and customer support.
- Build evidence for wellness claims, data privacy practices and any health-related product positioning before broad commercialization.
- Pursue distribution partnerships with premium fitness, healthcare, corporate-wellness or consumer platforms to reduce post-launch acquisition costs.
- Convert pre-launch interest into a waitlist, pilot cohort or subscription funnel that can demonstrate demand ahead of a larger funding round.